https://doi.org/10.4081/ijwc.2022.89
Observational study of a gauze medication contaning Rigenase® and polyhexanide in the treatiment of venous leg ulcers (<6cm2) and perilesional skin
Accepted: June 27, 2022
PDF (Italiano): 319
Appendix (Italiano): 40
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The Triticum Vulgare Extract (TVE) is a particular wheat extract patented by Farmaceutici Damor. TVE (Rigenase®) has been shown to have an important bio stimulation effect promoting the tissue repairing process in vitro. In this context, an observational study was developed to access the effects of a gauze based on Rigenase® and polyhexanide in the treatment of venous ulcers (area <6 cm2 and not beyond the dermal layer) and of damaged perilesional skin whose damage could have also been determined by iatrogenic cause. Inclusion and exclusion criteria were identified and a medication protocol was applied. The study showed that the product based on Rigenase® and polyhexanide is effective in the treatment of venous ulcers and damaged perilesional skin.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.